ArticleEuropean journal of haematology2026

Dose-Adjusted Treatment With 7-Day Venetoclax Plus Azacitidine or Decitabine in Patients With Acute Myeloid Leukaemia.

Laurenz Steiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.